[PDF][PDF] Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins

P Venkatraman, R Wetzel, M Tanaka, N Nukina… - Molecular cell, 2004 - cell.com
P Venkatraman, R Wetzel, M Tanaka, N Nukina, AL Goldberg
Molecular cell, 2004cell.com
Long glutamine sequences (polyQ) occur in many cell proteins, and several
neurodegenerative diseases result from expansion of these sequences. PolyQ-containing
proteins are degraded by proteasomes, whose three active sites prefer to cleave after
hydrophobic, basic, or acidic residues. We tested whether these particles can digest a polyQ
chain. Eukaryotic 26S and 20S proteasomes failed to cut within stretches of 9–29Q residues
in peptides. While digesting a myoglobin Q 35 fusion protein, the proteasomes spared the …
Abstract
Long glutamine sequences (polyQ) occur in many cell proteins, and several neurodegenerative diseases result from expansion of these sequences. PolyQ-containing proteins are degraded by proteasomes, whose three active sites prefer to cleave after hydrophobic, basic, or acidic residues. We tested whether these particles can digest a polyQ chain. Eukaryotic 26S and 20S proteasomes failed to cut within stretches of 9–29Q residues in peptides. While digesting a myoglobin Q35 fusion protein, the proteasomes spared the polyQ sequence. In contrast, archaeal proteasomes, whose 14 active sites are less specific, rapidly digested such polyQ repeats. Therefore, when degrading polyQ proteins, eukaryotic proteasomes must release aggregation-prone polyQ-containing fragments for further hydrolysis by unidentified peptidases. In polyQ diseases, such polyQ sequences (38–300Qs) exceed the lengths of normal proteasome products (2–25 residues). Occasional failure of these long undegradable sequences to exit may interfere with proteasome function and help explain why longer polyQ expansions promote early disease onset.
cell.com